139 related articles for article (PubMed ID: 31622036)
1. Omics-based Identification of Glycan Structures as Biomarkers for a Variety of Diseases.
Akiyoshi S; Iwata M; Berenger F; Yamanishi Y
Mol Inform; 2020 Jan; 39(1-2):e1900112. PubMed ID: 31622036
[TBL] [Abstract][Full Text] [Related]
2. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Thomas D; Rathinavel AK; Radhakrishnan P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
[TBL] [Abstract][Full Text] [Related]
3. Alteration of N-glycans and expression of their related glycogenes in the epithelial-mesenchymal transition of HCV29 bladder epithelial cells.
Guo J; Li X; Tan Z; Lu W; Yang G; Guan F
Molecules; 2014 Dec; 19(12):20073-90. PubMed ID: 25470275
[TBL] [Abstract][Full Text] [Related]
4. Identification of drug responsible glycogene signature in liver carcinoma from meta-analysis using RNA-seq data.
Koreeda T; Honda H
Glycoconj J; 2024 Apr; 41(2):133-149. PubMed ID: 38656600
[TBL] [Abstract][Full Text] [Related]
5. Altered N-Glycan expression profile in epithelial-to-mesenchymal transition of NMuMG cells revealed by an integrated strategy using mass spectrometry and glycogene and lectin microarray analysis.
Tan Z; Lu W; Li X; Yang G; Guo J; Yu H; Li Z; Guan F
J Proteome Res; 2014 Jun; 13(6):2783-95. PubMed ID: 24724545
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 and glycomics tools for
Gas-Pascual E; Ichikawa HT; Sheikh MO; Serji MI; Deng B; Mandalasi M; Bandini G; Samuelson J; Wells L; West CM
J Biol Chem; 2019 Jan; 294(4):1104-1125. PubMed ID: 30463938
[TBL] [Abstract][Full Text] [Related]
7. In Situ Cellular Glycan Analysis.
Chen Y; Ding L; Ju H
Acc Chem Res; 2018 Apr; 51(4):890-899. PubMed ID: 29595964
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers.
Kannagi R; Sakuma K; Miyazaki K; Lim KT; Yusa A; Yin J; Izawa M
Cancer Sci; 2010 Mar; 101(3):586-93. PubMed ID: 20085584
[TBL] [Abstract][Full Text] [Related]
9. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
10. Insights into miRNA regulation of the human glycome.
Kasper BT; Koppolu S; Mahal LK
Biochem Biophys Res Commun; 2014 Mar; 445(4):774-9. PubMed ID: 24463102
[TBL] [Abstract][Full Text] [Related]
11. Hallmarks of glycogene expression and glycosylation pathways in squamous and adenocarcinoma cervical cancer.
Martinez-Morales P; Morán Cruz I; Roa-de la Cruz L; Maycotte P; Reyes Salinas JS; Vazquez Zamora VJ; Gutierrez Quiroz CT; Montiel-Jarquin AJ; Vallejo-Ruiz V
PeerJ; 2021; 9():e12081. PubMed ID: 34540372
[TBL] [Abstract][Full Text] [Related]
12. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
13. Extraction of species-specific glycan substructures.
Hizukuri Y; Yamanishi Y; Hashimoto K; Kanehisa M
Genome Inform; 2004; 15(1):69-81. PubMed ID: 15712111
[TBL] [Abstract][Full Text] [Related]
14. Functional roles of glycogene and N-glycan in multidrug resistance of human breast cancer cells.
Ma H; Miao X; Ma Q; Zheng W; Zhou H; Jia L
IUBMB Life; 2013 May; 65(5):409-22. PubMed ID: 23441047
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.
Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G
J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355
[TBL] [Abstract][Full Text] [Related]
16. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z
Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277
[TBL] [Abstract][Full Text] [Related]
17. Alterations of high-mannose type N-glycosylation in human and mouse osteoarthritis cartilage.
Urita A; Matsuhashi T; Onodera T; Nakagawa H; Hato M; Amano M; Seito N; Minami A; Nishimura S; Iwasaki N
Arthritis Rheum; 2011 Nov; 63(11):3428-38. PubMed ID: 21834068
[TBL] [Abstract][Full Text] [Related]
18. Glycans as cancer biomarkers.
Adamczyk B; Tharmalingam T; Rudd PM
Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
[TBL] [Abstract][Full Text] [Related]
19. Glycosyltransferase Gene Expression Identifies a Poor Prognostic Colorectal Cancer Subtype Associated with Mismatch Repair Deficiency and Incomplete Glycan Synthesis.
Noda M; Okayama H; Tachibana K; Sakamoto W; Saito K; Thar Min AK; Ashizawa M; Nakajima T; Aoto K; Momma T; Katakura K; Ohki S; Kono K
Clin Cancer Res; 2018 Sep; 24(18):4468-4481. PubMed ID: 29844132
[No Abstract] [Full Text] [Related]
20. In silico simulation of glycosylation and related pathways.
Akune-Taylor Y; Kon A; Aoki-Kinoshita KF
Anal Bioanal Chem; 2024 Jul; 416(16):3687-3696. PubMed ID: 38748247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
